Watchlist Manager

Watchlist

Price: 1.18 HKD -0.84% Market Closed

Market Cap: HK$694.8m

	Lee's Pharmaceutical Holdings Ltd HKEX:950	HK
	Yifeng Pharmacy Chain Co Ltd SSE:603939	CN
	Aries Agro Ltd (CN) BSE:532935	IN
T	Timee Inc TSE:215A	JP
	Magazine Luiza SA OTC:MGLUY	BR

Balance Sheet

Currency: HKD

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	0	14	4	11	4	5	6	18	61	66	94	159	203	269	278	295	274	222	365	375	278	189	171	217
Cash	0	14	4	11	4	5	6	18	61	66	94	159	203	269	278	295	274	222	365	375	278	189	171	217
Short-Term Investments	0	0	0	0	0	0	10	5	0	55	41	175	176	124	116	210	181	207	410	39	0	0	0	0
Total Receivables	5	3	4	7	7	8	21	26	30	61	84	112	143	198	277	214	226	314	370	386	354	213	185	280
Accounts Receivables	2	2	1	4	4	4	9	18	13	41	58	72	78	100	108	87	86	149	153	160	168	111	85	161
Other Receivables	2	1	2	3	3	4	12	8	16	20	26	40	64	98	169	127	141	164	217	227	186	102	101	119
Inventory	1	1	2	4	4	4	9	7	27	23	35	64	118	139	170	135	161	212	256	414	331	249	298	288
Other Current Assets	0	1	8	2	2	2	2	2	2	2	2	2	2	0	0	29	31	49	40	24	0	0	2	0
Total Current Assets	6	19	18	23	16	19	48	57	119	206	256	512	642	730	841	884	873	1 005	1 441	1 239	963	652	657	785
PP&E Net	11	16	15	14	12	15	15	20	25	27	47	129	263	303	356	437	566	609	796	725	688	541	443	401
PP&E Gross	11	16	15	14	12	15	15	20	25	27	47	129	263	303	356	437	566	609	796	725	688	541	443	401
Accumulated Depreciation	4	5	7	8	9	10	13	15	19	22	29	39	39	42	67	95	146	177	261	360	476	527	615	645
Intangible Assets	7	11	11	12	14	14	18	27	59	65	87	127	194	236	338	422	449	587	695	845	923	1 023	1 077	1 135
Goodwill	0	0	0	0	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
Long-Term Investments	0	0	0	0	0	0	0	0	0	9	8	10	48	82	163	180	290	670	690	422	1 043	555	699	285
Other Long-Term Assets	0	3	0	0	1	1	1	1	1	1	8	15	15	14	149	135	143	132	14	19	15	8	10	8
Other Assets	0	0	0	0	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
Total Assets	23 N/A	48 +110%	45 -8%	49 +11%	47 -5%	53 +12%	87 +65%	108 +25%	209 +93%	312 +49%	410 +32%	797 +94%	1 166 +46%	1 369 +17%	1 851 +35%	2 061 +11%	2 325 +13%	3 007 +29%	3 640 +21%	3 253 -11%	3 637 +12%	2 782 -24%	2 891 +4%	2 618 -9%
Liabilities
Accounts Payable	1	1	1	1	1	1	6	2	2	2	9	29	37	42	38	42	26	66	80	74	63	101	74	142
Accrued Liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14	29	49	55	113	69	58	75
Short-Term Debt	4	8	4	5	7	11	4	4	8	18	17	32	70	52	67	134	99	129	145	141	163	0	0	0
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	10	8	13	84	130	158
Other Current Liabilities	4	4	6	6	4	7	14	15	41	41	57	112	166	214	177	182	291	452	625	666	572	396	387	396
Total Current Liabilities	8	12	11	12	11	18	24	21	51	61	84	173	272	308	282	358	431	677	908	944	923	650	649	771
Long-Term Debt	6	1	4	0	0	1	1	0	9	0	1	0	0	0	1	1	1	1	13	8	92	80	75	70
Deferred Income Tax	0	0	1	1	1	1	1	2	4	9	13	13	15	16	18	25	40	28	72	82	79	74	73	84
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	11	66	65	49	33	7	28	182	34	73	82	78	103
Other Liabilities	5	0	0	0	0	0	0	0	0	0	0	17	27	47	33	42	56	63	169	104	152	136	133	144
Total Liabilities	19 N/A	13 -31%	16 +18%	13 -19%	11 -10%	19 +73%	26 +33%	23 -12%	64 +182%	71 +11%	98 +39%	214 +118%	380 +77%	435 +15%	384 -12%	460 +20%	520 +13%	796 +53%	1 344 +69%	1 103 -18%	1 172 +6%	858 -27%	852 -1%	966 +13%
Equity
Common Stock	18	15	15	17	17	17	21	21	23	23	24	26	27	27	29	30	30	30	29	29	29	29	29	29
Retained Earnings	14	9	14	18	18	21	10	13	51	103	166	256	378	528	760	949	1 097	1 477	1 635	1 675	3 641	3 680	3 687	3 763
Additional Paid In Capital	0	25	25	33	33	33	44	45	64	103	106	261	292	301	718	721	725	732	714	715	720	720	720	720
Unrealized Security Profit/Loss	0	5	4	4	3	3	4	4	4	4	4	4	0	3	1	13	30	34	8	254	1 949	2 433	2 293	2 713
Other Equity	0	0	0	0	1	2	3	4	4	8	13	35	89	75	39	85	16	62	74	15	23	72	105	148
Total Equity	4 N/A	35 +763%	29 -18%	37 +27%	36 -3%	33 -7%	61 +83%	85 +40%	145 +70%	241 +67%	312 +29%	582 +87%	786 +35%	934 +19%	1 467 +57%	1 602 +9%	1 804 +13%	2 211 +23%	2 296 +4%	2 150 -6%	2 465 +15%	1 924 -22%	2 039 +6%	1 652 -19%
Total Liabilities & Equity	23 N/A	48 +110%	45 -8%	49 +11%	47 -5%	53 +12%	87 +65%	108 +25%	209 +93%	312 +49%	410 +32%	797 +94%	1 166 +46%	1 369 +17%	1 851 +35%	2 061 +11%	2 325 +13%	3 007 +29%	3 640 +21%	3 253 -11%	3 637 +12%	2 782 -24%	2 891 +4%	2 618 -9%
Shares Outstanding
Common Shares Outstanding	214	289	289	346	346	346	413	415	450	466	470	521	538	545	587	590	591	592	588	588	589	589	589	589

Income Statement Balance Sheet Cash Flow Statement

Lee's Pharmaceutical Holdings Ltd
HKEX:950

Balance Sheet

Balance Sheet Decomposition
Lee's Pharmaceutical Holdings Ltd

Balance Sheet
Lee's Pharmaceutical Holdings Ltd

See Also

Company

Help

Tools

Stocks

Lee's Pharmaceutical Holdings Ltd HKEX:950

Balance Sheet

Balance Sheet Decomposition Lee's Pharmaceutical Holdings Ltd

Balance Sheet Lee's Pharmaceutical Holdings Ltd

See Also

Company

Help

Tools

Stocks

Lee's Pharmaceutical Holdings Ltd
HKEX:950

Balance Sheet Decomposition
Lee's Pharmaceutical Holdings Ltd

Balance Sheet
Lee's Pharmaceutical Holdings Ltd